openPR Logo
Press release

Virus-Like Particles Market Expected To Witness Incredible Growth And Forecast 2024-2033

01-10-2024 01:46 PM CET | Health & Medicine

Press release from: Global Insight Services

Virus-Like Particles Market

Virus-Like Particles Market

Market Definition

Virus-like particles (VLPs) are multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccine candidates.

Market Outlook

The global Virus-Like Particles (VLP's) Market was valued at USD 4.6 Billion in 2022 and it is anticipated to grow up to USD 8.9 Billion by 2032, at a CAGR of 6.8% during the forecast period.

Virus-like particles (VLPs) are multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccine candidates.

Consistent R&D activities prominently drive the growth of the overall market. VLPs have gained attention from many researchers, particularly virologists and immunologists. VLP-based vaccines are more immunogenic and safer than traditional vaccines as they cannot replicate, recombine, or undergo reassortment due to the lack of infectious DNA or RNA material.

To Know More: https://www.globalinsightservices.com/reports/virus-like-particles-market/?utm_id=1017

Research Objectives

• Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region
• Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
• Identify factors influencing market growth and challenges, opportunities, drivers and restraints
• Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
• Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
• Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
• To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.
• Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives

Request Sample: https://www.globalinsightservices.com/request-sample/GIS10500/?utm_id=1017

Global Virus-Like Particles (VLP's) Market Segmental Overview

The report analyses the global Virus-Like Particles (VLP's) Market based on product type, source, application, and region. Global Virus-Like Particles (VLP's) Market by Product Type Based on product type, the virus-like particles market is segmented as hepatitis, cancer/HPV, and Gaucher disease. The hepatitis segment would account for a large market share during 2021-2028. For instance, as per the data published by the Hepatitis B Foundations in 2021, about two billion people are infected with the hepatitis B virus worldwide. To counter such situation utilization of commercialized VLPs vaccines proved effective for hepatitis treatment. Examples of commercialized VLP vaccines are "Recombivax" and "Engerix". These two are the recently commercialized VLP-based vaccines for hepatitis B, and "Gardasil" and "Cervarix" and both are the licensed VLP-based vaccine for human papillomavirus. Today, VLP based vaccines against hepatitis C virus, Ebola, Lassa virus, hantavirus, Marburg, SARS coronavirus, and Chikungunya virus, among others, are in various stages of developmen.
Global Virus-Like Particles (VLP's) Market by Source By source, the virus-like particles market is segmented into yeast, insect cell, plant, and others. Based on the source, the yeast segment will record dominating share for the overall market in the coming years. Yeast cells are frequently used for recombinant proteins expression and have been widely used for VLP vaccine production. This is mainly due to advantages such as rapid cell growth, high protein expression yield, easy scalability, cost-effective production, and high degree of post-translational modification (PTM) processes. The Food and Drug Administration (FDA) has approved two VLP-based vaccines - Engerix-B (HBV vaccine) and Gardasil (HPV vaccine) - produced using yeast expression systems.

Global Virus-Like Particles (VLP's) Market by Application By application, the virus-like particles market is segmented as vaccines and therapeutics. The vaccines segment would hold a considerable share of the market in 2021, and it is likely to continue its dominance in the market during the forecast period as well. VLP-based vaccines have been developed as an alternative to traditional vaccines owing to their safety, flexibility, and distinctive immunogenic properties. The transmission of infectious or deadly viruses such as HCV poses a serious threat to populations worldwide. The introduction of an HCV vaccine has been projected using simulation models in a high-risk population with posing a significant effect on reducing the incidence of HCV. For example, to avoid such situation, simulation model has been developed by the government focusing on vaccination program aiming to reduce incidences of HCV. Simulation models has proven track record of reducing hepatitis C prevalence through VLP vaccine. With even modest efficacy and coverage VLP vaccine significantly reduces the incidence of hepatitis C among the population as the vaccine has effectiveness up to 50-80% efficacy, targeted to high-risk intravenous drug users, could dramatically reduce HCV incidence among the population. Therefore, VLPs based vaccine represents a safe and highly immunogenic vaccine delivery platform that is able to induce a potent adaptive immune response.

Request Customization: https://www.globalinsightservices.com/request-customization/GIS10500/?utm_id=1017

Major Players in the Global Virus-Like Particles (VLP's) Market
The key players in the Virus-Like Particles (VLP's) Market Merck & Co., Inc., GlaxoSmithKline plc., Pfizer Inc., Dynavax Technologies, Sanofi, Wantai BioPharm, Serum Institute of India Pvt. Ltd., BHARAT BIOTECH, LG Chem, and VBI Vaccines Inc.. among others.

Request Discounted Pricing: https://www.globalinsightservices.com/request-special-pricing/GIS10500/?utm_id=1017

Research Scope

• Scope - Highlights, Trends, Insights. Attractiveness, Forecast
• Market Sizing - Product Type, End User, Offering Type, Technology, Region, Country, Others
• Market Dynamics - Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain
• Business Framework - Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
• Competitive Landscape - Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
• Company Profiles - Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.
• Market Size in 2021 - US$ 4.6 Billion
• Market Size in 2031 - US$ 8.9 Billion
• CAGR - 6.8 %
• Historic Period - 2016-2022
• Forecast Period - 2024-2033
• Base Year - 2024

Buy your copy here: https://www.globalinsightservices.com/checkout/single_user/GIS10500/?utm_id=1017

With Global Insight Services, you receive:

• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Infographic excel data pack, easy to analyze big data
• Robust and transparent research methodology
•Unmatched data quality and after sales service

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Virus-Like Particles Market Expected To Witness Incredible Growth And Forecast 2024-2033 here

News-ID: 3348255 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for VLP

VLP Ultra Low Profile Copper Foil Research:the global market share will reach 39 …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2024 latest report "VLP Ultra Low Profile Copper Foil- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030". Based on current situation and impact historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the
Malaria Vaccines Market Overall Study Report 2024-2031 | GlaxoSmithKline, Nobelp …
Malaria Vaccines Market Trends Overview 2024-2031: A new Report by Coherent Market Insights, titled "Malaria Vaccines Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Malaria Vaccines market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful
Creative Diagnostics Announces the Launch of Norovirus VLP Antigens to Support V …
Creative Diagnostics announces its new line of Norovirus VLP Antigens for in vitro diagnostics and vaccine research. Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the availability of its new line of Norovirus VLP Antigens [https://www.creative-diagnostics.com/new-norovirus-vlp-antigens.htm] to accelerate in vitro diagnostics and vaccine research. These new antigens have been validated to a high level of confidence using electron microscopy. Norovirus is a non-enveloped,
Malaria Vaccines Market Is Booming Worldwide 2024-2031 | GlaxoSmithKline, Nobelp …
New Research report, titled "Malaria Vaccines Market" Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the worldwide market. The Malaria Vaccines market has been growing significantly in recent years, driven by a number of key factors, such as increasing
VLP Vaccines Market 2023: Some Basic Influencing Factors Making It's Booming Ind …
The VLP Vaccines market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The VLP Vaccines report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. The VLP Vaccines research report also provides insights of different regions that are
Plant-Based Virus-Like Particles (VLP) Technology Market Present Scenario and Gr …
The report offers a thorough investigation of the various patterns as well as factors impacting the progression of the global Plant-Based Virus-Like Particles (VLP) Technology market. It has in-depth data associated with the overarching development of the market and shows new development predictions for the global market in light of strong data. An assessment of the impacts of government plans on the market procedures is likewise added to offer an